Financial News

Artal Group takes stake in Crispr Therapeutics

Artal Group acquired 50,000 shares of Crispr Therapeutics (Nasdaq: CRSP). Shares of the gene editing company leaped $5.30 to close at $48.34.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info